UK markets closed

NIKKEI 225
31,872.52
-499.38(-1.54%)
HANG SENG
17,373.03
-238.84(-1.36%)
CRUDE OIL
91.55
-2.13(-2.27%)
GOLD FUTURES
1,878.70
-12.20(-0.65%)
DOW
33,599.91
+49.64(+0.15%)
Bitcoin GBP
22,264.32
+802.70(+3.74%)

Celebrity houses on the market

Check out these luxurious homes owned by the stars

Newron Pharmaceuticals S.p.A. (NWPHF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

6.22

0.00

(0.00%)

As of 10:46AM EDT. Market open.

Loading interactive chart…

Business Wire
Newron Announces H1 2023 Results and Provides R&D Update
MILAN, August 04, 2023--Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the half year ended June 30, 2023, and provided an update on its R&D and business activities.
Business Wire
Newron Presents Exciting New Data From Study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
MILAN, May 15, 2023--Newron presents exciting new data from two international medical conferences on its Phase II trial of evenamide for treatment resistant schizophrenia
Business Wire
Newron to Present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
MILAN, May 03, 2023--Newron to present further data from its study 014/015 on evenamide for treatment resistant schizophrenia at two international congresses in May 2023.